NO20000577D0 - Eprosartanarginyl-ladning-noeytraliseringskompleks g en fremgangsmåte for dets fremstilling og formuulering - Google Patents

Eprosartanarginyl-ladning-noeytraliseringskompleks g en fremgangsmåte for dets fremstilling og formuulering

Info

Publication number
NO20000577D0
NO20000577D0 NO20000577A NO20000577A NO20000577D0 NO 20000577 D0 NO20000577 D0 NO 20000577D0 NO 20000577 A NO20000577 A NO 20000577A NO 20000577 A NO20000577 A NO 20000577A NO 20000577 D0 NO20000577 D0 NO 20000577D0
Authority
NO
Norway
Prior art keywords
eprosartanarginyl
formulation
charge
preparation
neutralization complex
Prior art date
Application number
NO20000577A
Other languages
English (en)
Other versions
NO317771B1 (no
NO20000577L (no
Inventor
Manga R Gudipati
Gopadi M Venkatesh
Nageswara R Palepu
John M Jushcyshyn
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of NO20000577D0 publication Critical patent/NO20000577D0/no
Publication of NO20000577L publication Critical patent/NO20000577L/no
Publication of NO317771B1 publication Critical patent/NO317771B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
NO20000577A 1997-08-06 2000-02-04 Eprosartanarginyl-ladning-noytraliseringskompleks og en fremgangsmate for dets fremstilling og anvendelse derav NO317771B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5499097P 1997-08-06 1997-08-06
PCT/US1998/016245 WO1999007365A1 (en) 1997-08-06 1998-08-04 Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation

Publications (3)

Publication Number Publication Date
NO20000577D0 true NO20000577D0 (no) 2000-02-04
NO20000577L NO20000577L (no) 2000-02-29
NO317771B1 NO317771B1 (no) 2004-12-13

Family

ID=21994861

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000577A NO317771B1 (no) 1997-08-06 2000-02-04 Eprosartanarginyl-ladning-noytraliseringskompleks og en fremgangsmate for dets fremstilling og anvendelse derav

Country Status (27)

Country Link
EP (1) EP1027047B1 (no)
JP (1) JP4463975B2 (no)
KR (1) KR100508044B1 (no)
CN (1) CN1276724A (no)
AR (1) AR015930A1 (no)
AT (1) ATE341325T1 (no)
AU (1) AU739295B2 (no)
BR (1) BR9811926A (no)
CA (1) CA2299470C (no)
CO (1) CO4960666A1 (no)
CY (1) CY1105851T1 (no)
CZ (1) CZ296274B6 (no)
DE (1) DE69836095T2 (no)
DK (1) DK1027047T3 (no)
ES (1) ES2273433T3 (no)
HK (1) HK1031688A1 (no)
HU (1) HUP0201624A3 (no)
IL (1) IL134378A (no)
NO (1) NO317771B1 (no)
NZ (1) NZ502644A (no)
PL (1) PL198875B1 (no)
PT (1) PT1027047E (no)
SA (1) SA98190592B1 (no)
TR (1) TR200000350T2 (no)
TW (1) TW570921B (no)
WO (1) WO1999007365A1 (no)
ZA (1) ZA987018B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA991922B (en) * 1998-03-11 1999-09-13 Smithkline Beecham Corp Novel compositions of eprosartan.
EP1197223B1 (en) * 1999-04-28 2005-02-16 Takeda Pharmaceutical Company Limited Preventives / remedies / progression inhibitors for simplex retinopathy or preproliferating retinopathy
BRPI0406987A (pt) 2003-01-31 2006-01-10 Sankyo Co Medicamento para a prevenção e/ou tratamento de arteriosclerose, medicamentos para a inibição de proliferação de células do músculo liso vascular, de formação de neoìntima dos vasos sanguìneos e de remodelação vascular, medicamento para a prevenção de restenose que segue intervenção coronária percutânea, e, medicamentos para a profilaxia e/ou tratamento de hipertensão ou doenças causadas por hipertensão ou doenças causadas por hipertensão, de doenças cardìacas, de angina do peito, de infarto miocárdico, de arritmia, de morte súbita, de insuficiência cardìaca, de hipertrofia cardìaca, de doenças renais, de nefropatia diabética, de glomerulonefrite, de nefrosclerose, de doenças cerebrovasculares, de infarto cerebral, e de hemorragia cerebral
NO323391B1 (no) 2005-09-28 2007-04-23 Hts Hans Torgersen & Sonn As Barnepose
EP2167047A2 (en) * 2007-06-06 2010-03-31 Dexcel Ltd. Process for forming solid oral dosage forms of angiotensin ii receptor antagonists
JP5476782B2 (ja) * 2009-04-21 2014-04-23 大正製薬株式会社 アルギニン含有錠剤の製造方法
JP5446716B2 (ja) * 2009-10-21 2014-03-19 大正製薬株式会社 アルギニン及びカルニチン含有錠剤の製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5185351A (en) * 1989-06-14 1993-02-09 Smithkline Beecham Corporation Imidazolyl-alkenoic acids useful as angiotensin II receptor antagonists
NZ239161A (en) * 1990-07-31 1994-01-26 Smithkline Beecham Corp Substituted [1h-imidazol-5-yl] alkanoic acid derivatives; medicaments,
DE69131021T2 (de) * 1990-12-14 1999-08-12 Smithkline Beecham Corp Angiotensin-ii-rezeptor blockierende zusammensetzungen
JP3214856B2 (ja) * 1990-12-14 2001-10-02 スミスクライン・ビーチャム・コーポレイション イミダゾリル−アルケン酸
US5187159A (en) * 1991-10-07 1993-02-16 Merck & Co., Inc. Angiotensin II antagonists incorporating a substituted 1,3-benzodioxole or 1,3-benzodithiole
DE4208052A1 (de) * 1992-03-13 1993-09-16 Bayer Ag Imidazolyl substituierte phenylessigsaeureamide
FR2688781B1 (fr) * 1992-03-23 1994-07-01 Sanofi Elf Imidazolines n-substituees par un groupement biphenylmethyle, leur preparation, les compositions pharmaceutiques en contenant.
DE4210787A1 (de) * 1992-04-01 1993-10-07 Bayer Ag Cycloalkyl- und Heterocyclyl substituierte Imidazolylpropensäurederivate
JPH0841053A (ja) * 1994-07-28 1996-02-13 Nkk Corp ヘテロアリールアルキル基を有するピリミジン誘導体及 び該誘導体を有効成分として含有するアンジオテンシン ｉｉ拮抗剤
US5645839A (en) * 1995-06-07 1997-07-08 Trustees Of Boston University Combined use of angiotensin inhibitors and nitric oxide stimulators to treat fibrosis
WO1997021707A1 (en) * 1995-12-14 1997-06-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
EP1027047A4 (en) 2002-09-18
CZ296274B6 (cs) 2006-02-15
TR200000350T2 (tr) 2000-12-21
JP4463975B2 (ja) 2010-05-19
WO1999007365A1 (en) 1999-02-18
CY1105851T1 (el) 2011-02-02
EP1027047B1 (en) 2006-10-04
JP2001513498A (ja) 2001-09-04
IL134378A0 (en) 2001-04-30
AU739295B2 (en) 2001-10-11
BR9811926A (pt) 2000-08-22
AU8768898A (en) 1999-03-01
CZ2000406A3 (cs) 2000-09-13
NO317771B1 (no) 2004-12-13
HUP0201624A2 (hu) 2002-12-28
ES2273433T3 (es) 2007-05-01
CA2299470C (en) 2010-01-26
NZ502644A (en) 2002-03-01
PL198875B1 (pl) 2008-07-31
DE69836095D1 (de) 2006-11-16
CO4960666A1 (es) 2000-09-25
HUP0201624A3 (en) 2003-03-28
CA2299470A1 (en) 1999-02-18
KR100508044B1 (ko) 2005-08-17
DE69836095T2 (de) 2007-04-12
ATE341325T1 (de) 2006-10-15
PT1027047E (pt) 2007-01-31
EP1027047A1 (en) 2000-08-16
AR015930A1 (es) 2001-05-30
HK1031688A1 (en) 2001-06-22
KR20010022582A (ko) 2001-03-26
TW570921B (en) 2004-01-11
DK1027047T3 (da) 2007-01-29
SA98190592B1 (ar) 2006-06-20
NO20000577L (no) 2000-02-29
IL134378A (en) 2004-02-19
ZA987018B (en) 1999-02-08
PL341562A1 (en) 2001-04-23
CN1276724A (zh) 2000-12-13

Similar Documents

Publication Publication Date Title
DK0739898T3 (da) Phosphononmoneosternukleinsyrer, fremgangsmåde til fremstilling deraf og anvendelse deraf
NO20035726D0 (no) Benzopyran-inneholdende forbindelser og fremgangsmåte for anvendelse derav
NO994392L (no) Oksiranderivat og fremgangsmate for dets fremstilling
NO985240D0 (no) Nµringsmiddel med fyll og en fremgangsmÕte ved fremstilling derav
NO984503D0 (no) Eprosartandihydrat og en fremgangsmÕte for dets fremstilling og formulering
NO940825D0 (no) 2-Debenzoyl-2-acyltaxolderivater og fremgangsmåter ved fremstilling derav
NO20000602L (no) Krembasert matsammensetning og fremgangsmåte for fremstilling derav
NO972451D0 (no) 2-heterocyklyloksy og tiometyl-1,2,5-tiadiazolidin-3-on 1,1-dioksider og preparater og fremgangsmåte for anvendelse derav
DK0992794T3 (da) Enzym-antistofkompleks og en fremgangsmåde til fremstilling heraf
DK0991666T3 (da) Alfa-1-antitrypsin-præparat og fremgangsmåde til fremstilling heraf
NO951447D0 (no) Organoaluminoksyprodukt, fremstilling og anvendelse
AP2000001829A0 (en) Substituted thiazolidinedione derivative process for its preparation and its pharmaceutical use
NO20002202D0 (no) Støpte polyolefin- og polyfenyloksidprodukter og fremgangsmÕte til fremstilling derav
DK1003383T4 (da) Smagsforstærkende N-ethyl-p-menthan-3-carboxamidindeholdende forbindelser og fremgangsmåde til fremstilling og anvendelse deraf
DK0909271T3 (da) Indolyl-pyrrolylidenmethylpyrrolderivater og en fremgangsmåde til fremstilling deraf
NO980403L (no) Katalytisk blanding og fremgangsmaate for fremstilling derav
DK0735042T3 (da) Maltitolsammensætning og fremgangsmåde til fremstilling deraf
NO940801L (no) Fremgangsmåte og komponenter for alternativ forskaling
NO20000577D0 (no) Eprosartanarginyl-ladning-noeytraliseringskompleks g en fremgangsmåte for dets fremstilling og formuulering
NO954207D0 (no) Preparat inneholdende kolestyramin og fremgangsmåte for dets fremstilling
PT1086077E (pt) Novos antiestrogeneos processo para a sua preparacao e sua utilizacao farmaceutica
NO960766D0 (no) Nytt protein og fremgangsmåte for fremstilling av dette
GB2294459B (en) Anti-efflorescence admixture for concrete products
HUP0004510A3 (en) Process for obtaining l-dihydroorotic acid and use thereof
NO993863L (no) Forbindelser og fremgangsmÕte for fremstilling av substituerte 4-fenyl-4-cyanocycloheksansyrer

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees